Top

Neurocritical Care

Published in:

01-04-2019 | Original Article

Third Ventricle Obstruction by Thalamic Intracerebral Hemorrhage Predicts Poor Functional Outcome Among Patients Treated with Alteplase in the CLEAR III Trial

Authors: Natalie L. Ullman, Pouya Tahsili-Fahadan, Carol B. Thompson, Wendy C. Ziai, Daniel F. Hanley

Published in: Neurocritical Care | Issue 2/2019

Abstract

Introduction

The Clot Lysis: Evaluating Accelerated Resolution of IVH trial examined whether irrigating the ventricular system with alteplase improved functional outcomes in patients with small intracerebral hemorrhage (ICH) and large intraventricular hemorrhage (IVH). Thalamic ICH location was common and was associated with poor outcome. One possible explanation is thalamic ICH-associated mass effect obstructing the third ventricle. We hypothesized that patients with thalamic ICH obstructing the third ventricle would have worse functional outcomes compared to patients without obstructing lesions.

Methods

ICH obstruction of third ventricle was defined as third ventricle compression on 1 or more axial computed tomography slices visually impeding cerebral spinal fluid flow. If the third ventricle was casted with IVH, it was scored as such. Multivariable logistic regression analyses were used to determine whether obstruction of the third ventricle predicts poor functional outcomes defined as modified Rankin score (mRS) 4–6, higher mRS, and mortality at 180 days. Models were adjusted for thalamic ICH location, ICH volume, IVH volume, age, hydrocephalus, baseline Glasgow coma scale, and percentage of low cerebral perfusion pressures during treatment.

Results

Among saline-treated patients, obstruction of the third ventricle by IVH was a significant predictor of higher mRS at 180 days (OR 1.87, CI 1.01–3.47) and mortality at 180 days (OR 2.73, CI 1.27–5.87) while obstruction by ICH was not. In contrast, among alteplase-treated patients, obstruction by ICH was a significant predictor of mRS 4–6 (OR 3.20, CI 1.30–7.88) and higher mRS at 180 days (OR 2.33, CI 1.24–4.35), while obstruction by IVH was not.

Conclusions

Poor outcomes were associated with mass-related obstruction of the third ventricle from thalamic ICH in alteplase-treated patients and from IVH in saline-treated patients. Once the ventricular system is cleared with alteplase, obstruction of cerebral spinal fluid flow from thalamic ICH might become important in functional recovery.

Broderick JP, Brott T, Tomsick T, Miller R, Huster G. Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage. J Neurosurg. 1993;78(2):188–91.CrossRefPubMed

Hallevi H, Albright KC, Aronowski J, Barreto AD, Martin-Schild S, Khaja AM, et al. Intraventricular hemorrhage: anatomic relationships and clinical implications. Neurology. 2008;70(11):848–52.CrossRefPubMedPubMedCentral

Moradiya Y, Murthy SB, Newman-Toker DE, Hanley DF, Ziai WC. Intraventricular thrombolysis in intracerebral hemorrhage requiring ventriculostomy: a decade-long real-world experience. Stroke. 2014;45(9):2629–35.CrossRefPubMedPubMedCentral

Gaberel T, Magheru C, Parienti JJ, Huttner HB, Vivien D, Emery E. Intraventricular fibrinolysis versus external ventricular drainage alone in intraventricular hemorrhage: a meta-analysis. Stroke. 2011;42(10):2776–81.CrossRef

Nieuwkamp DJ, de Gans K, Rinkel GJ, Algra A. Treatment and outcome of severe intraventricular extension in patients with subarachnoid or intracerebral hemorrhage: a systematic review of the literature. J Neurol. 2000;247(2):117–21.CrossRefPubMed

Naff N, Williams MA, Keyl PM, Tuhrim S, Bullock MR, Mayer SA, et al. Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial. Stroke. 2011;42(11):3009–16.CrossRefPubMedPubMedCentral

Hanley DF, Lane K, McBee N, Ziai W, Tuhrim S, Lees KR, et al. Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial. Lancet. 2017;389(10069):603–11.CrossRefPubMedPubMedCentral

Ziai WC, Tuhrim S, Lane K, McBee N, Lees K, Dawson J, et al. A multicenter, randomized, double-blinded, placebo-controlled phase III study of Clot Lysis Evaluation of Accelerated Resolution of Intraventricular Hemorrhage (CLEAR III). Int J Stroke. 2014;9(4):536–42.CrossRefPubMed

Ziai WC, Melnychuk E, Thompson CB, Awad I, Lane K, Hanley DF. Occurrence and impact of intracranial pressure elevation during treatment of severe intraventricular hemorrhage. Crit Care Med. 2012;40(5):1601–8.CrossRefPubMedPubMedCentral

10.

Delcourt C, Sato S, Zhang S, Sandset EC, Zheng D, Chen X, et al. Intracerebral hemorrhage location and outcome among INTERACT2 participants. Neurology. 2017;88(15):1408–14.CrossRefPubMedPubMedCentral

11.

Eslami V, Nekoobakht-Tak S, Tahsili-Fahadan P, Dlugash R, McBee N, Lane K, et al. Influence of intracerebral hemorrhage location in patients with spontaneous intraventricular hemorrhage results from the clot lysis: evaluating accelerated resolution of intraventricular hemorrhage (CLEAR) III trial. In: Annual MEETING of the Neurocritical Care Society 2016, National Harbor, MD.

12.

Zacharia BE, Vaughan KA, Hickman ZL, Bruce SS, Carpenter AM, Petersen NH, et al. Predictors of long-term shunt-dependent hydrocephalus in patients with intracerebral hemorrhage requiring emergency cerebrospinal fluid diversion. Neurosurg Focus. 2012;32(4):E5.CrossRefPubMed

13.

Miller C, Tsivgoulis G, Nakaji P. Predictors of ventriculoperitoneal shunting after spontaneous intraparenchymal hemorrhage. Neurocrit Care. 2008;8(2):235–40.CrossRefPubMed

14.

Ng LK, Schwarz G, Mishkin MM. Hematoma from arteriovenous malformation producing hydrocephalus and simulating a thalamic tumor. Report of two cases. J Neurosurg. 1971;34(2 Pt 1):229–35.CrossRefPubMed

15.

Tokumitsu N, Sako K, Kunimoto M, Nakai H, Yonemasu Y. Glial cyst in the thalamus with intracystic hemorrhage—case report. Neurol Med Chir (Tokyo). 1997;37(3):284–7.CrossRef

16.

Mahta A, Katz PM, Kamel H, Azizi SA. Intracerebral hemorrhage with intraventricular extension and no hydrocephalus may not increase mortality or severe disability. J Clin Neurosci. 2016;30:56–9.CrossRefPubMed

17.

Diringer MN, Edwards DF, Zazulia AR. Hydrocephalus: a previously unrecognized predictor of poor outcome from supratentorial intracerebral hemorrhage. Stroke. 1998;29(7):1352–7.CrossRefPubMed

18.

Hansen BM, Ullman N, Norrving B, Hanley DF, Lindgren A. Applicability of clinical trials in an unselected cohort of patients with intracerebral hemorrhage. Stroke. 2016;47(10):2634–7.CrossRefPubMedPubMedCentral

Title: Third Ventricle Obstruction by Thalamic Intracerebral Hemorrhage Predicts Poor Functional Outcome Among Patients Treated with Alteplase in the CLEAR III Trial
Authors: Natalie L. Ullman
Pouya Tahsili-Fahadan
Carol B. Thompson
Wendy C. Ziai
Daniel F. Hanley
Publication date: 01-04-2019
Publisher: Springer US
Published in: Neurocritical Care / Issue 2/2019
Print ISSN: 1541-6933
Electronic ISSN: 1556-0961
DOI: https://doi.org/10.1007/s12028-018-0610-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Third Ventricle Obstruction by Thalamic Intracerebral Hemorrhage Predicts Poor Functional Outcome Among Patients Treated with Alteplase in the CLEAR III Trial

Abstract

Introduction

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Introduction

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2019

Intracranial Pressure Evaluation in Acute Liver Failure

And the Beat Goes on…Heart Rate Variability After Spontaneous Intracranial Hemorrhage

Early Manipulation of Arterial Blood Pressure in Acute Ischemic Stroke (MAPAS): Results of a Randomized Controlled Trial

Temporal Dynamics of Cerebral Blood Flow During the Acute Course of Severe Subarachnoid Hemorrhage Studied by Bedside Xenon-Enhanced CT

Tactical Neurocritical Care

Author’s Response to Letter to the Editor: Noninvasive Intracranial Pressure Assessment in Acute Liver Failure